Skip to content

Awarded to GOLDEN STATE MEDICAL SUPPLY INC on February 15, 2023

This is an award notice, not an open solicitation. Related open opportunities are listed below.

Olopatadine HCL 0.1% Ophthalmic Solution

DEPT OF DEFENSE

Notice type
Award Notice
Solicitation #
SPE2D222R0117
NAICS
325412
PSC
6505
Posted
September 24, 2026
Response due
—
Place of performance
Ontario, Canada

What this opportunity is

The Department of Defense is procuring Olopatadine HCL 0.1% ophthalmic solution, classified under the NAICS code 325412 and PSC 6505. This opportunity may suit small businesses in the pharmaceutical manufacturing sector, particularly those specializing in ophthalmic products. As this is an award notice, interested parties should note that the opportunity has already been awarded, indicating that tracking similar future opportunities may be more beneficial than bidding at this stage.

Analysis by Mindy, grounded in the SAM.gov notice.

Description

Modification SPE2D223D0007 P00013 No-Cost Settlement Termination for Convenience. Modification SPE2D223D0007 P00012 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle. Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23. Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract. Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle

Source: SAM.gov, as posted. Verify the current solicitation before responding.

Get alerts when DEPT OF DEFENSE posts the next one

Mindy watches SAM.gov every day and emails you new notices that match what you sell — like NAICS 325412. Free daily alerts.

View the original notice on SAM.gov ↗

Open opportunities in NAICS 325412